These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29023896)

  • 41. Blood transfusion in sickle cell disease.
    Marouf R
    Hemoglobin; 2011; 35(5-6):495-502. PubMed ID: 21981466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Measurements of red cell deformability and hydration reflect HbF and HbA
    Parrow NL; Tu H; Nichols J; Violet PC; Pittman CA; Fitzhugh C; Fleming RE; Mohandas N; Tisdale JF; Levine M
    Blood Cells Mol Dis; 2017 Jun; 65():41-50. PubMed ID: 28472705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. With a simple calculation, the fraction of platelets remaining can be used to estimate the residual hemoglobin S percentage in sickle cell disease patients undergoing automated red blood cell exchange.
    Keiser AM; Booth GS; Gehrie EA
    Transfus Apher Sci; 2018 Apr; 57(2):250-252. PubMed ID: 29567367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Transfusion in sickle cell anemia].
    Bachir D; Bonnet-Gajdos M; Galacteros F
    Presse Med; 1990 Oct; 19(35):1627-31. PubMed ID: 2147256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute normovolemic red cell exchange for cardiopulmonary bypass in sickle cell disease.
    Shulman G; McQuitty C; Vertrees RA; Conti VR
    Ann Thorac Surg; 1998 May; 65(5):1444-6. PubMed ID: 9594885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transfusion medicine illustrated. Hemoglobin D after a red-cell exchange for sickle-cell disease.
    Brecher ME; Park YA; Whinna HC; McClannan LS; Afenyi-Annan A
    Transfusion; 2008 Nov; 48(11):2277-8. PubMed ID: 19054375
    [No Abstract]   [Full Text] [Related]  

  • 47. Assessment of the use of transfusion therapy perioperatively in patients with sickle cell hemoglobinopathies.
    Bischoff RJ; Williamson A; Dalali MJ; Rice JC; Kerstein MD
    Ann Surg; 1988 Apr; 207(4):434-8. PubMed ID: 3355266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum zinc, copper and magnesium in sickle cell disease at Ibadan, south western Nigeria.
    Akenami FO; Aken'Ova YA; Osifo BO
    Afr J Med Med Sci; 1999; 28(3-4):137-9. PubMed ID: 11205817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Painful sickle cell crises precipitated by stopping prophylactic exchange transfusions.
    Keidan AJ; Marwah SS; Vaughan GR; Franklin IM; Stuart J
    J Clin Pathol; 1987 May; 40(5):505-7. PubMed ID: 3584499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcome of pregnancies complicated by sickle cell and sickle-C hemoglobinopathies.
    Seoud MA; Cantwell C; Nobles G; Levy DL
    Am J Perinatol; 1994 May; 11(3):187-91. PubMed ID: 8048982
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Perioperative monitoring of hemoglobin fractions in homozygous sickle cell disease].
    Frietsch T; Segiet W; Schütz P; Haux P; Lorentz A
    Anaesthesist; 1999 Apr; 48(4):231-5. PubMed ID: 10352787
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Minor elective surgical procedures using general anesthesia in children with sickle cell anemia without pre-operative blood transfusion.
    Fu T; Corrigan NJ; Quinn CT; Rogers ZR; Buchanan GR
    Pediatr Blood Cancer; 2005 Jul; 45(1):43-7. PubMed ID: 15880471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Continuous and noninvasive hemoglobin monitoring reduces red blood cell transfusion during neurosurgery: a prospective cohort study.
    Awada WN; Mohmoued MF; Radwan TM; Hussien GZ; Elkady HW
    J Clin Monit Comput; 2015 Dec; 29(6):733-40. PubMed ID: 25649717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of blood transfusion on exercise capacity in patients with sickle-cell anemia.
    Charache S; Bleecker ER; Bross DS
    Am J Med; 1983 May; 74(5):757-64. PubMed ID: 6837600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of transfusion practices in sickle cell disease in Senegal: cohort study of 1078 patients with sickle cell disease.
    Seck M; Tall A; Faye BF; Bah DS; Guéye Y; Sall A; Touré AO; Diop S
    Med Sante Trop; 2017 Nov; 27(4):402-406. PubMed ID: 29313508
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using the daily rate of rise in hemoglobin S to manage RBC depletion/exchange treatment in sickle cell disease.
    Rogers K; Alsawas M; Chapman J; Schlueter AJ; Knudson CM
    Transfusion; 2024 Apr; 64(4):685-692. PubMed ID: 38506484
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Open heart surgery in patients with sickle cell hemoglobinopathy.
    Yousafzai SM; Ugurlucan M; Al Radhwan OA; Al Otaibi AL; Canver CC
    Circulation; 2010 Jan; 121(1):14-9. PubMed ID: 20026775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pregnancy and sickle cell hemoglobinopathies: results with and without prophylactic transfusions.
    Cunningham FG; Pritchard JA; Mason R
    Obstet Gynecol; 1983 Oct; 62(4):419-24. PubMed ID: 6888818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma cortisol in sickle cell disease.
    Osifo BO; Lukanmbi FA; Adekile A
    Acta Haematol; 1988; 79(1):44-5. PubMed ID: 3124460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calculating the required transfusion volume in children.
    Davies P; Robertson S; Hegde S; Greenwood R; Massey E; Davis P
    Transfusion; 2007 Feb; 47(2):212-6. PubMed ID: 17302766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.